(1259) Factors That Impact Pharmacists' Recommendation of Simultaneous Administration of Vaccines in a Mass-market Retail Pharmacy"

Objectives: Vaccine coadministration is a proven method that maximizes protection for patients, and also minimizes resource expenditure in the day-to-day operations of pharmacies. Several strategies have been implemented to encourage coadministration of vaccines including, but not limited to, the training of technicians to ask about additional vaccines at the point of sale, age-based recommendation forms at the time of consent, and technology prompts at the time of vaccine preparation. All these tactics lead to a conversation with the pharmacist, and it is vital to know what might influence the decision to, or not to administer vaccines together. Even with these procedures in place, coadministration data is not routinely reported. The objective of this study is to compare factors that affect coadministration prevalence among pharmacists who administer and supervise administration of vaccines, and to quantify companywide coadministration data in the setting of a mass-market retail pharmacy.

Methods: Three hundred mass-market retail pharmacies will be selected at random across the United States to receive electronic anonymous surveys for all pharmacists who operate at the selected stores. The selection process will be witnessed. This survey will address pharmacist confidence levels, views on workflow, desire for additional coadministration data, personal preference, and hesitancy with specific vaccines. The survey will be available from November 1st, 2023, to November 30th, 2023. This survey will only be sent to stores in states that allow pharmacist administration of all ACIP recommended vaccines. The companywide coadministration report will be generated by vaccine administration data pulled internally by the company from July 1st, 2023, to October 31st, 2023. Total coadministration percent is to be reported, defined as the number of patients who received 2 or more vaccines divided by the total number of patients who received any vaccine. Results will then be stratified by age group and vaccine type. Data will only be collected for stores in states that allow pharmacist administration all ACIP recommended vaccines. Results will be analyzed using descriptive statistics.

Results: N/A

Conclusions: N/A